The PREMM1,2,6 Model Predicts Risk of MLH1, MSH2, and MSH6 Germline Mutations Based on Cancer History

This publication has 28 references indexed in Scilit:

• 1028 Comparison of the Clinical Prediction Model Premm1,2,6 With Colorectal Cancer Molecular Tumor Testing for Lynch Syndrome in the Colon Cancer Family Registry
  Gastroenterology, 2010
• Risks of Lynch Syndrome Cancers for MSH6 Mutation Carriers
  JNCI Journal of the National Cancer Institute, 2010
• Calculation of Risk of Colorectal and Endometrial Cancer Among Patients With Lynch Syndrome
  Gastroenterology, 2009
• Validation of predictive models for germline mutations in DNA mismatch repair genes in colorectal cancer
  International Journal of Cancer, 2009
• A comparison of models used to predict MLH1, MSH2 and MSH6 mutation carriers
  Annals of Oncology, 2009
• Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients
  Journal of Medical Genetics, 2008
• Validation and Extension of the PREMM1,2 Model in a Population-Based Cohort of Colorectal Cancer Patients
  Gastroenterology, 2008
• Prediction of Germline Mutations and Cancer Risk in the Lynch Syndrome
  JAMA, 2006
• Lower Incidence of Colorectal Cancer and Later Age of Disease Onset in 27 Families With Pathogenic MSH6 Germline Mutations Compared With Families With MLH1 or MSH2 Mutations: The German Hereditary Nonpolyposis Colorectal Cancer Consortium
  Journal of Clinical Oncology, 2004
• The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)
  Diseases of the Colon & Rectum, 1991